-
Mashup Score: 0Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study - 1 year(s) ago
Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
In this RCT, treatment with methylprednisolone in children with PIMS-TS did not significantly affect the length of hospital stay compared with intravenous immunoglobulins. Intravenous methylprednisolone could be an acceptable first-line treatment in children with PIMS-TS.
Categories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 1 year(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 6What Is PIMS | Long Covid Kids - 2 year(s) ago
Paediatric Inflammatory Multisystem Syndrome (PIMS) is deemed to be a rare condition thought to be triggered by COVID-19. Although it is a relatively new condition, it can be detected early and treated successfully. PIMS is also known as Multisystem Inflammatory Syndrome in Children (MIS-C).
Source: Long Covid KidsCategories: Latest Headlines, NursingTweet
-
Mashup Score: 0Genetic mutation may identify women with difficulty producing breast milk | Penn State University - 2 year(s) ago
Penn State College of Medicine researchers found that women who stopped breastfeeding because they believed they had inadequate milk supply are more likely to have a specific mutation in a gene found in mammary tissue.
Source: www.psu.eduCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 7One-Year Outcomes of Critical Care Patients Post–COVID-19 Multisystem Inflammatory Syndrome in Children - 2 year(s) ago
This study examines 1-year outcomes of critical care patients in the UK after COVID-19 multisystem inflammatory syndrome in children.
Source: jamanetwork.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 64th AIIMS-NCGR-COVID-19: Children with COVID-19, Multisystem Inflammatory Syndrome in Children - 3 year(s) ago
Case Discussion: – Children with COVID-19Summary Topics: – Challenges in managing children with COVID-19 Multisystem Inflammatory Syndrome in ChildrenThe All…
Source: YouTubeCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 26Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents - 3 year(s) ago
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents
Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 10
zeit.de with ads Um der Nutzung mit Werbung zuzustimmen, muss JavaScript in Ihrem Browser aktiviert sein. zeit.de with ads Visit…
Source: www.zeit.deCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19 - 3 year(s) ago
This cohort study describes the various otolaryngologic manifestations in and rates among patients 18 years or younger with pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2.
Source: jamanetwork.comCategories: Latest Headlines, OtolaryngologyTweet
NEW RESEARCH from the @BATStudy—Initial treatment for #MISC with glucocorticoids is associated with similar outcomes to treatment with intravenous immunoglobulin or combined therapy, including resolution of coronary artery aneurysms https://t.co/saefomBDFU #PIMS-TS #OpenAccess https://t.co/AEa4D8a1Y5